filmov
tv
Tackling the New Bottleneck of Drug Discovery
Показать описание
Markus Gershater, chief scientific officer and co-founder of Synthace sits down with Amar Drawid to discuss Synthace’s AI-based platform that enables drug developers to design complex experiments, run them, and capture and analyze the data all in an automated way.
0:57:21
0:06:20
0:03:04
0:15:22
0:00:53
0:11:34
0:05:50
0:18:48
0:10:31
0:05:15
0:00:41
1:05:26
0:02:38
0:02:40
0:10:45
0:01:50
0:01:45
0:05:14
0:00:28
0:04:45
0:16:51
0:39:29
0:32:57
0:05:57